ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BeiGene Announces Acceptance of its First NDA for Zanubrutinib
August 30, 2018Zanubrutinib is being studied in several clinical trials as part of a broad development program and was recently granted Fast Track Designation by the US FDA -
CDA approves Gilead’s chronic hepatitis C virus infection drug
June 01, 2018HCV is the fourth-most commonly reported infectious disease in China, with approximately 10 million people infected. HCV genotypes 1, 2, 3 and 6 account for more than 96 percent of all cases.
Pharma Sources Insight January 2025
